FDA Alignment to Advance ProstACT Global Phase 3 Trial

Go back to FDA Alignment to Advance ProstACT Global Phase 3 Trial
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.33 +0.12 (1.07%)
Previous Close $11.21    52 Week High $2.18 
Open $11.30    52 Week Low $0.30 
Day High $11.39    P/E N/A 
Day Low $11.30    EPS $-3.32 
Volume 38,809       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.33 +0.12 (1.07%)
Previous Close $11.21    52 Week High $2.18 
Open $11.30    52 Week Low $0.30 
Day High $11.39    P/E N/A 
Day Low $11.30    EPS $-3.32 
Volume 38,809